{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:52:10Z","timestamp":1788871930695,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","award":["NR9317"],"award-info":[{"award-number":["NR9317"]}],"id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","award":["NS10406"],"award-info":[{"award-number":["NS10406"]}],"id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["LC06027"],"award-info":[{"award-number":["LC06027"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["MSM0021622415"],"award-info":[{"award-number":["MSM0021622415"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["MSM0021622434"],"award-info":[{"award-number":["MSM0021622434"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.leukres.2009.12.018","type":"journal-article","created":{"date-parts":[[2010,1,22]],"date-time":"2010-01-22T05:17:42Z","timestamp":1264137462000},"page":"1007-1011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Centrosome amplification as a possible marker of mitotic disruptions and cellular carcinogenesis in multiple myeloma"],"prefix":"10.1016","volume":"34","author":[{"given":"E.","family":"Dementyeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Nemec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kryukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.R.","family":"Muthu Raja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Smetana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Zaoralova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Greslikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kupska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Kuglik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hajek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2009.12.018_bib1","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1101\/gad.894001","article-title":"\u201cIt takes two to tango\u201d: understanding how centrosome duplication is regulated throughout the cell cycle","volume":"15","author":"Hinchcliffe","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.leukres.2009.12.018_bib2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.leu.2402454","article-title":"Centrosome replication, genomic instability and cancer","volume":"16","author":"Kr\u00e4mer","year":"2002","journal-title":"Leukemia"},{"issue":"13","key":"10.1016\/j.leukres.2009.12.018_bib3","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1158\/0008-5472.CAN-07-0663","article-title":"Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen","volume":"67","author":"Rebacz","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2009.12.018_bib4","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1038\/sj.onc.1205775","article-title":"On the role of aurora-A in centrosome function","volume":"21","author":"Dutertre","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2009.12.018_bib5","first-page":"3974","article-title":"Centrosome defects and genetic instability in malignant tumors","volume":"58","author":"Pihan","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2009.12.018_bib6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nrc924","article-title":"Centrosome aberrations: cause or consequence of cancer progression?","volume":"2","author":"Nigg","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.leukres.2009.12.018_bib7","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1073\/pnas.95.6.2950","article-title":"Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity","volume":"95","author":"Lingle","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.leukres.2009.12.018_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood-2002-04-1188","article-title":"Centrosome aberrations in acute myeloid leukemia are correlated with cytogenetic risk profile","volume":"101","author":"Neben","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.12.018_bib9","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/sj.leu.2403780","article-title":"Centrosome aberrations\u2014hen or egg in cancer initiation and progression?","volume":"19","author":"Kr\u00e4mer","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2009.12.018_bib10","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1182\/blood-2005-09-3810","article-title":"Clinical implication of centrosome amplification in plasma cell neoplasm","volume":"107","author":"Chng","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.12.018_bib11","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2005-02-0761","article-title":"A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS","volume":"106","author":"Chng","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.12.018_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0165-4608(97)00058-7","article-title":"A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies","volume":"101","author":"Ahmann","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.leukres.2009.12.018_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0955-0674(95)80043-3","article-title":"Centrin, centrosomes, and mitotic spindle poles","volume":"7","author":"Salisbury","year":"1995","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.leukres.2009.12.018_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4149\/neo_2010_02_111","article-title":"Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation","volume":"57","author":"Greslikova","year":"2010","journal-title":"Neoplasma"},{"issue":"17","key":"10.1016\/j.leukres.2009.12.018_bib15","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1200\/JCO.2007.15.8428","article-title":"Multiple myeloma cancer stem cells","volume":"26","author":"Huff","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2009.12.018_bib16","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2009.12.018_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V57.2.333.333","article-title":"The growth fraction of human myeloma cells","volume":"57","author":"Drewinko","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.12.018_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood.V58.3.471.471","article-title":"Drug resistance in multiple myeloma associated with high in vitro incorporation of 3H-thymidine","volume":"58","author":"Hofmann","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.12.018_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood.V59.1.43.43","article-title":"Ploidy and proliferative characteristics in monoclonal gammopathies","volume":"59","author":"Latreille","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.12.018_bib20","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood-2003-09-3064","article-title":"Characterization of clonogenic multiple myeloma cells","volume":"103","author":"Matsui","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.12.018_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1158\/0008-5472.CAN-07-3096","article-title":"Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance","volume":"68","author":"Matsui","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2009.12.018_bib22","first-page":"371","article-title":"Monoclonal lymphocyte population in human plasma cell myeloma","volume":"17","author":"Mellstedt","year":"1974","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.leukres.2009.12.018_bib23","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1084\/jem.150.4.792","article-title":"Studies on the clonal origin of multiple myeloma: use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation","volume":"150","author":"Kubagawa","year":"1979","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2009.12.018_bib24","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.V73.7.1925.1925","article-title":"Tumor cell heterogeneity in multiple myeloma: antigenic, morphologic, and functional studies of cells from blood and bone marrow","volume":"73","author":"King","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.12.018_bib25","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1046\/j.1365-2141.2002.03529.x","article-title":"Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance","volume":"117","author":"Zojer","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2009.12.018_bib26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2141.1998.00525.x","article-title":"B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors","volume":"100","author":"Rawstron","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2009.12.018_bib27","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1182\/blood.V87.8.3375.bloodjournal8783375","article-title":"Plasma cells induce apoptosis of pre-B cells by interacting with bone marrow stromal cells","volume":"87","author":"Tsujimoto","year":"1996","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609006006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609006006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:56:40Z","timestamp":1758934600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609006006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0145212609006006"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2009.12.018","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Centrosome amplification as a possible marker of mitotic disruptions and cellular carcinogenesis in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2009.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}